Today: 27 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent stock hugs IBM’s $31 bid — here’s what investors watch next week

Confluent shares closed at $30.57 Friday, 43 cents below IBM’s $31-per-share cash offer, ahead of key events next week. The company will report earnings Feb. 11 without a call or outlook, and shareholders vote on the merger Feb. 12. Confluent disclosed 17 demand letters and two lawsuits over proxy disclosures but denies wrongdoing. The IBM deal values Confluent at $11 billion.
7 February 2026
··
BitMine Immersion (BMNR) stock whipsaws with ether — what to watch before Monday

BitMine Immersion (BMNR) stock whipsaws with ether — what to watch before Monday

BitMine Immersion Technologies shares rose 16.8% to $20.32 Friday after a 14.3% drop Thursday, tracking sharp swings in ether and bitcoin. Trading volume hit 54 million shares. The company held over 4.2 million ether and 193 bitcoin as of Feb. 1, with nearly 2.9 million ether staked, according to an SEC filing. Crypto price moves over the weekend are expected to drive Monday’s open.
7 February 2026
·
Coherent stock whiplash: COHR jumps after earnings drop — what to watch next week

Coherent stock whiplash: COHR jumps after earnings drop — what to watch next week

Coherent Corp shares jumped 8.8% to $227.68 Friday, rebounding after a two-day slide following its quarterly results. The company reported December-quarter revenue of $1.69 billion and non-GAAP earnings of $1.29 a share, with datacenter and communications driving 72% of sales. Barclays, Stifel, and JPMorgan raised price targets to $235–$245. FMR LLC disclosed a 15% stake as of Dec. 31.
7 February 2026
··
Palo Alto Networks stock snaps back after sharp slide as NextWave overhaul lands before earnings

Palo Alto Networks stock snaps back after sharp slide as NextWave overhaul lands before earnings

Palo Alto Networks shares closed up 2.9% at $159.32 on Friday, recovering part of Thursday’s 7.2% drop. The company announced a revamped NextWave partner program focused on bundled security platforms. Software stocks rebounded with the broader market after heavy losses earlier in the week. Investors await Palo Alto’s Feb. 17 earnings for signs of demand and margins.
7 February 2026
····
MPWR stock jumps to a new high: what to know after Monolithic Power Systems’ upbeat outlook

MPWR stock jumps to a new high: what to know after Monolithic Power Systems’ upbeat outlook

Monolithic Power Systems shares jumped 6.4% to $1,229.82, hitting a 52-week high after reporting Q4 revenue of $751.2 million and raising its dividend to $2.00 per share. The company forecast March-quarter revenue of $770–$790 million and announced CFO Bernie Blegen will retire, with Rob Dean as interim CFO. Needham raised its price target to $1,300.
7 February 2026
··
Nebius (NBIS) stock jumps 16% into weekend as AI trade whipsaws; earnings next week in focus

Nebius (NBIS) stock jumps 16% into weekend as AI trade whipsaws; earnings next week in focus

Nebius shares jumped 16.6% to $86.10 on Friday, rebounding from a 10.3% drop Thursday. The company will report fourth-quarter and full-year 2025 results before the market opens on Feb. 12. U.S. jobs and inflation data are due next week after a delay from a government shutdown. Recent swings in Nebius stock followed volatility in AI-linked tech names after Alphabet’s spending update.
7 February 2026
··
AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

AST SpaceMobile shares jumped 9.1% to $101.79 Friday after a volatile week, with 15.9 million shares traded. AT&T said it will use Amazon Leo’s satellite network to reach business customers outside its terrestrial footprint but stated this will not affect its partnership with AST. A new 2x short ETF tied to ASTS, ticker ASTN, began trading on Cboe. AST’s next “BlueBird 7” satellite launch is set for late February on Blue Origin’s New Glenn.
7 February 2026
·····
Super Micro (SMCI) stock jumps, but SEC filing flags margin squeeze and customer concentration

Super Micro (SMCI) stock jumps, but SEC filing flags margin squeeze and customer concentration

Super Micro Computer shares jumped 11.4% to $34.38 Friday, then slipped 0.9% after hours. Quarterly sales rose 123% to $12.68 billion, but gross margin dropped to 6.3%. Tariff costs, inventory write-downs, and dependence on a single customer weighed on results. The company disclosed an SEC subpoena and a March 12 court date in a securities case.
7 February 2026
···
1 … 152 153 154 155 156 … 758

Stock Market Today

  • Dollar Dips on Iran Peace Hopes, Oil Prices Rise
    April 27, 2026, 5:35 PM EDT. The U.S. dollar dipped from a 2.5-week high amid reports that Iran proposed reopening the Strait of Hormuz, a strategic oil passage, suggesting potential easing of US-Iran tensions. Axios reported the plan includes extending the ceasefire before nuclear talks, with the White House reviewing the proposal. Despite higher crude oil prices lifting inflation expectations-a factor that usually strengthens the dollar-uncertainty over US Federal Reserve interest rate moves and rate hike cutbacks in 2026 weighed on the currency. The dollar index fell 0.05%, while the euro saw modest gains supported by dollar weakness but constrained by weak German consumer and business confidence. The yen weakened slightly amid Japan's rising stock market and higher bond yields. Markets now price near zero chance of a Fed rate hike at this week's meeting.

Latest article

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

Oruka Therapeutics Stock Surges After Psoriasis Drug Data as Biotech Seeks $500 Million

27 April 2026
Oruka Therapeutics reported its experimental psoriasis drug ORKA-001 achieved complete skin clearance in 63.5% of patients at 16 weeks. Shares jumped 10.5% to $76.39 before the company launched a $500 million public offering. No serious adverse events were reported in the trial. ORKA-001 is being developed as a long-acting injectable, with annual dosing possible.
Why Rambus Stock Fell Even as AI Memory Sales Jumped in Q1

Why Rambus Stock Fell Even as AI Memory Sales Jumped in Q1

27 April 2026
Rambus shares fell 10.8% to $141.31 Monday after reporting first-quarter revenue of $180.2 million and net income of $59.9 million. Product revenue rose 15% to $88 million, driven by AI data-center demand. The company forecast higher second-quarter product revenue but said results depend on customer deals. Rambus recently launched a new server memory module aimed at AI systems.
Go toTop